Advertisement

Oncological outcome of proximal and middle extrahepatic bile duct cancer according to surgical extent (Is hilar resection oncologically acceptable in proximal and middle extrahepatic bile duct cancer?)

Published:September 30, 2022DOI:https://doi.org/10.1016/j.hpb.2022.09.009

      Abstract

      Background

      For proximal to middle bile duct cancer, it is controversial whether bile duct resection alone is sufficient, or whether hepatic or pancreatic resection should be accompanied by initial planning. This study aimed to determine the optimal surgical extent based on oncological outcomes in patients with proximal to middle bile duct cancer.

      Methods

      Patients who underwent surgery for proximal to middle extrahepatic bile duct cancer, hilar resection, or combined resection of other organs were included. Clinicopathological characteristics and survival analyses were compared according to operation type.

      Results

      Among 156 patients in total, R0 rate was 56.7% for hilar resection and 82.7% for other organ resection. Although hilar resection was associated with shorter hospital stay and fewer overall complications, operation type did not affect overall survival (p = 0.259) and disease-free-survival (p = 0.774). Overall survival differed according to R status (5YSR 49.8 vs. 27.1%; p = 0.012).

      Conclusion

      In proximal to middle extrahepatic bile duct cancer, surgery should be tailored to achieve R0 resection according to the extent of the disease rather than uniformly resecting extensively with other organ resections. Hilar resection could be selected if R0 resection is feasible, considering the lower morbidity with similar long-term survival.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to HPB
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Clements O.
        • Eliahoo J.
        • Kim J.U.
        • Taylor-Robinson S.D.
        • Khan S.A.
        Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
        J Hepatol. 2020; 72: 95-103
        • Doherty B.
        • Nambudiri V.E.
        • Palmer W.C.
        Update on the diagnosis and treatment of cholangiocarcinoma.
        Curr Gastroenterol Rep. 2017; 19: 2
        • Schreuder A.M.
        • Engelsman A.F.
        • van Roessel S.
        • Verheij J.
        • Besselink M.G.
        • van Gulik T.M.
        • et al.
        Treatment of mid-bile duct carcinoma: local resection or pancreatoduodenectomy?.
        Eur J Surg Oncol. 2019; 45: 2180-2187
        • Lewis H.L.
        • Rahnemai-Azar A.A.
        • Dillhoff M.
        • Schmidt C.R.
        • Pawlik T.M.
        Current management of perihilar cholangiocarcinoma and future perspectives.
        Chirurgia (Bucur). 2017; 112: 193-207
        • Hayashi H.
        • Jang J.Y.
        • Kim K.S.
        • Choi J.S.
        • Takahara T.
        • Choi S.H.
        • et al.
        Comparison of pancreaticoduodenectomy and bile duct resection for middle bile duct cancer: a multi-center collaborating study of Japan and Korea.
        J Hepatobiliary Pancreat Sci. 2020; 27: 289-298
        • Sakamoto Y.
        • Shimada K.
        • Nara S.
        • Esaki M.
        • Ojima H.
        • Sano T.
        • et al.
        Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients.
        J Gastrointest Surg. 2010; 14: 335-343
        • Jarnagin W.R.
        • Fong Y.
        • DeMatteo R.P.
        • Gonen M.
        • Burke E.C.
        • Bodniewicz B.J.
        • et al.
        Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
        Ann Surg. 2001; 234 (; discussion 17-9): 507-517
        • Ikeyama T.
        • Nagino M.
        • Oda K.
        • Ebata T.
        • Nishio H.
        • Nimura Y.
        Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases.
        Ann Surg. 2007; 246: 1052-1057
        • Xiong J.
        • Nunes Q.M.
        • Huang W.
        • Wei A.
        • Ke N.
        • Mai G.
        • et al.
        Major hepatectomy in Bismuth types I and II hilar cholangiocarcinoma.
        J Surg Res. 2015; 194: 194-201
        • Chen R.X.
        • Li C.X.
        • Luo C.H.
        • Zhang H.
        • Zhou T.
        • Wu X.F.
        • et al.
        Surgical strategies for the treatment of bismuth type I and II hilar cholangiocarcinoma: bile duct resection with or without hepatectomy?.
        Ann Surg Oncol. 2020; 27: 3374-3382
        • Jonas S.
        • Benckert C.
        • Thelen A.
        • Lopez-Hänninen E.
        • Rösch T.
        • Neuhaus P.
        Radical surgery for hilar cholangiocarcinoma.
        Eur J Surg Oncol. 2008; 34: 263-271
        • Jang J.Y.
        • Kim S.W.
        • Park D.J.
        • Ahn Y.J.
        • Yoon Y.S.
        • Choi M.G.
        • et al.
        Actual long-term outcome of extrahepatic bile duct cancer after surgical resection.
        Ann Surg. 2005; 241: 77-84
        • Xiang S.
        • Lau W.Y.
        • Chen X.P.
        Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure.
        Int J Colorectal Dis. 2015; 30: 159-171
        • Schreuder A.M.
        • Engelsman A.F.
        • van Roessel S.
        • Verheij J.
        • Besselink M.G.
        • van Gulik T.M.
        • et al.
        Treatment of mid-bile duct carcinoma: local resection or pancreatoduodenectomy?.
        Eur J Surg Oncol. 2019; 45: 2180-2187
        • Ercolani G.
        • Dazzi A.
        • Giovinazzo F.
        • Ruzzenente A.
        • Bassi C.
        • Guglielmi A.
        • et al.
        Intrahepatic, peri-hilar and distal cholangiocarcinoma: three different locations of the same tumor or three different tumors?.
        Eur J Surg Oncol. 2015; 41: 1162-1169
        • Esnaola N.F.
        • Meyer J.E.
        • Karachristos A.
        • Maranki J.L.
        • Camp E.R.
        • Denlinger C.S.
        Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
        Cancer. 2016; 122: 1349-1369
        • Zhang X.F.
        • Zhang N.
        • Tsilimigras D.I.
        • Weber S.M.
        • Poultsides G.
        • Hatzaras I.
        • et al.
        Surgical strategies for bismuth type I and II hilar cholangiocarcinoma: impact on long-term outcomes.
        J Gastrointest Surg. 2021; 25: 3084-3091
        • Otani K.
        • Chijiiwa K.
        • Kai M.
        • Ohuchida J.
        • Nagano M.
        • Kondo K.
        Role of hilar resection in the treatment of hilar cholangiocarcinoma.
        Hepato-Gastroenterology. 2012; 59: 696-700
        • Lim J.H.
        • Choi G.H.
        • Choi S.H.
        • Kim K.S.
        • Choi J.S.
        • Lee W.J.
        Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma.
        World J Surg. 2013; 37: 829-837
        • Kondo S.
        • Hirano S.
        • Ambo Y.
        • Tanaka E.
        • Okushiba S.
        • Morikawa T.
        • et al.
        Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study.
        Ann Surg. 2004; 240: 95-101
        • Kim H.S.
        • Park J.W.
        • Kim H.
        • Han Y.
        • Kwon W.
        • Kim S.W.
        • et al.
        Optimal surgical treatment in patients with T1b gallbladder cancer: an international multicenter study.
        J Hepatobiliary Pancreat Sci. 2018; 25: 533-543
        • Schlemper R.J.
        • Itabashi M.
        • Kato Y.
        • Lewin K.J.
        • Riddell R.H.
        • Shimoda T.
        • et al.
        Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists.
        Lancet. 1997; 349: 1725-1729
        • Kim J.M.
        • Cho M.Y.
        • Sohn J.H.
        • Kang D.Y.
        • Park C.K.
        • Kim W.H.
        • et al.
        Diagnosis of gastric epithelial neoplasia: dilemma for Korean pathologists.
        World J Gastroenterol. 2011; 17: 2602-2610
        • Yoshida N.
        • Naito Y.
        • Inada Y.
        • Itoh Y.
        • Lee S.P.
        • Kim J.H.
        • et al.
        Cross-national analysis about the difference of histopathological management in Tis and T1 colorectal cancer between Japan and Korea.
        J Anus Rectum Colon. 2019; 3: 18-26